Large Study Maps Antibody Patterns Across Type 1 Diabetes and Other Autoimmune Diseases

For decades, researchers studying autoimmune diseases like Type 1 diabetes have focused on specific antibodies known to appear in each condition. But a new study took a wider approach: instead of testing for a handful of targets, scientists measured antibodies against 280 human proteins, plus 40 viruses and 15 bacteria, in blood samples from hundreds of patients.

The research, published in the Journal of Proteome Research, used an advanced platform called the Nucleic-Acid Programmable Protein Array to run these broad tests. The goal was to see what antibody patterns emerge when you look at autoimmune diseases side by side, rather than studying each one in isolation.

Among the 237 patients with eight autoimmune diseases, the Type 1 diabetes group showed both unique antibodies and shared ones. The researchers identified autoantibodies specific to T1D—antibodies the immune system produced against the body's own proteins—as well as autoantibodies that also appeared in other autoimmune conditions.

Two particularly notable autoantibodies, STNM4 and TRIM21, were found in T1D along with up to four other autoimmune diseases each. This overlap suggests that some immune mechanisms may be similar across different autoimmune conditions, even though the diseases affect different organs and systems.

An intriguing finding was that antibodies against certain viruses and bacteria also appeared across multiple autoimmune diseases, including Type 1 diabetes. For instance, antibodies against influenza, Coxsackievirus, and Enterovirus were detected in patients with T1D and other conditions.

This does not mean these infections cause autoimmune disease, but it raises questions researchers continue to explore: Could exposure to certain infections trigger the immune system to attack the body's own tissues? Do people who later develop autoimmune diseases respond differently to common viruses? These are open questions, and this study adds to the growing body of evidence suggesting infections may play some role in autoimmune disease development.

Understanding antibody patterns across autoimmune diseases can help researchers identify biomarkers—measurable biological signs that could be used to predict who might develop Type 1 diabetes, or to track how the disease progresses over time.

As scientists work toward better ways to prevent, delay, or treat Type 1 diabetes, having a clearer picture of which antibodies are specific to T1D and which are shared with other conditions is a step forward. It helps refine which markers might be most useful for screening, diagnosis, and understanding what's happening in the immune system at different stages of the disease.

Source: Journal of proteome research. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.